Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

meningococcal A/C conjugate vaccine

Home Drugsmeningococcal A/C conjugate vaccine

meningococcal A/C conjugate vaccine

Unknown Manufacturer

Generate AI report

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Meningococcal conjugate vaccine for groups A, C, Y and W135 and a preparation method thereof
Applicant: BEIJING SANROAD BIOLOGICAL PRODUCTS CO LTDPriority: 2015
US
COMBINED VACCINE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
Applicant: CANSINO BIOLOGICS INCPriority: 2023
CN
WO
2 publications
Preparation method of group C meningococcal capsular polysaccharide conjugate vaccine
Applicant: BEIJING CHENGDA TIANHE BIOTECHNOLOGY CO LTDPriority: 2016
CN
Preparation method of pentavalent meningococcal polysaccharide conjugate vaccine based on double-protein carrier and product of pentavalent meningococcal polysaccharide conjugate vaccine
Applicant: CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO LTDPriority: 2024
CN
Preparation method of group C meningococcal polysaccharide conjugate vaccine
Applicant: OLYMVAX BIOPHARMACEUTICALS INCPriority: 2016
CN
MENINGOCOCCAL HEXAVALENT COMBINATION VACCINE
Applicant: TECHINVENTION LIFECARE PRIVATE LTDPriority: 2024
WO
Conjugate vaccine
Applicant: BEIJING ZHIFEI LVZHOU BIOPHARMACEUTICAL CO LTDPriority: 2020
CN
Preparation method of group A meningococcal capsular polysaccharide conjugate vaccine
Applicant: OLYMVAX BIOPHARMACEUTICALS INCPriority: 2016
CN